Quantcast
Channel: MassDevice
Browsing all 12024 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Eurasian countries agree to harmonized medical device framework

By Stewart Eisenhart, Emergo Group An agreement to establish a harmonized regulatory system for medical devices across Russia and several former Soviet bloc countries has been signed, but few details...

View Article


Image may be NSFW.
Clik here to view.

Senate removes roadblocks to vote on FDA nominee Califf

The U.S. Senate yesterday moved closer to confirming Dr. Robert Califf to lead the FDA, overriding opposition from several senators who had sought to block a vote on the issue. In a procedural move...

View Article


Image may be NSFW.
Clik here to view.

TransMedics launches pivotal trial for OCS liver transplant system

TransMedics said today that it launched a pivotal study of its OCS Liver device, which is designed to keep donated human liver warm and perfused until transplantation. Andover, Mass.-based TransMedics...

View Article

Image may be NSFW.
Clik here to view.

FDA approves Boston Scientific’s Acuity X4 quad leads

Boston Scientific (NYSE:BSX) said today that it won pre-market approval from the FDA for its Acuity X4 quadripolar leads for its cardiac resynchronization devices. The approval marks the 1st time the...

View Article

Image may be NSFW.
Clik here to view.

Medtronic claims title to world’s 1st app-based remote monitoring for pacemakers

Medtronic (NYSE:MDT) said today that its Canadian subsidiary won approval there for the world’s 1st app-based remote monitor for pacemakers, the MyCareLink Smart system. The Health Canada nod allows...

View Article


Image may be NSFW.
Clik here to view.

InVivo Therapeutics enrolls 6th patient in spinal scaffold trial

InVivo Therapeutics (NSDQ:NVIV) shares are up this morning on the spinal scaffold maker’s announcement that it enrolled the 6th patient in its Inspire pivotal clinical trial. The patient, who’s being...

View Article

Image may be NSFW.
Clik here to view.

‘Stentrode’ could revolutionize thought-control tech

(Reuters) — Powered exoskeletons that allow the paralyzed to walk are at the forefront of medical technology. Now Australian scientists are set to revolutionize the field with an ambitious new project....

View Article

Image may be NSFW.
Clik here to view.

Over-allotment brings Titan Medical offering to $12m

Titan Medical (CVE:TMD) said today an over-allotment option on its most recent offering added another $1.1 million (CDN $1.6 million) through the sale of an additional 1.7 million units at 65¢ (CDN...

View Article


Image may be NSFW.
Clik here to view.

SpectraScience picks up optical imaging company Oncoscope

SpectraScience said today it acquired the assets of optical imaging system company Oncoscope for an undisclosed amount. Durham, N.C.-based Oncoscope developed a proprietary optical imaging system...

View Article


Image may be NSFW.
Clik here to view.

MassDevice.com +3 | The top 3 medtech stories for February 23, 2016

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...

View Article

Image may be NSFW.
Clik here to view.

RTI launches Unison-C cervical implant

RTI Surgical said today it launched its Unison-C anterior cervical fixation system designed and indicated for stand-alone anterior cervical interbody fusion procedures for treating degenerative disc...

View Article

Image may be NSFW.
Clik here to view.

Hologic touts 3D mammography study data

Hologic (NSDQ:HOLX) said today that a study of women screened for breast cancer over multiple years using its Genius 3D mammography system showed a significant drop in recalls. The findings, which...

View Article

Image may be NSFW.
Clik here to view.

Coll Plant jumps on CE Mark win for wound filler

CollPlant said today it won CE Mark approval in the European Union for its Vergenix FG flowable gel intended to treat chronic and acute wounds. In response to the news, the company’s share price was up...

View Article


Image may be NSFW.
Clik here to view.

J-Pac Medical offers dry room processing capabilities for assembly and...

J-Pac Medical announced its dry room processing capabilities for the packaging of environmentally-sensitive healthcare products. J-Pac’s dry room capabilities feature low humidity processing in Class 7...

View Article

Image may be NSFW.
Clik here to view.

Iran, a new frontier for medical device companies?

By Emad Elmasry, Emergo Group The recent lifting of Iranian sanctions opens up a new market to medical device manufacturers, one of the largest markets in the Middle East. If you are considering a...

View Article


Image may be NSFW.
Clik here to view.

NuVasive loses $42m sales poaching case

A federal jury in California slapped NuVasive Inc. (NSDQ:NUVA) with a $41.8 million judgment after finding that the spinal implant maker poached sales reps from 1 of its distributors. Madsen Medical,...

View Article

Image may be NSFW.
Clik here to view.

Nico wins $15 million for BrainPath neurosurgery device

Nico Corp. said it raised $15 million of a hoped-for $18 million funding round, led by prior backers River Cities Capital Funds and the Rose-Hulman Institute of Technology, for its BrainPath...

View Article


Image may be NSFW.
Clik here to view.

Bayer taps strategy head Baumann for CEO | Personnel Moves

Bayer (ETR:BAYN) named strategy chief Werner Baumann to replace Marijn Dekkers as CEO today, prompting some industry watchers to speculate that there’s more deal-making ahead for the German firm’s...

View Article

Image may be NSFW.
Clik here to view.

Greatbatch board OKs Nuvectra neurostim spinout

Greatbatch (NYSE:GB) said today that its board of directors approved the spinout of its QiG Group, which is slated to become Nuvectra Corp. once the deal closes, expected March 7. One Nuvectra share is...

View Article

Image may be NSFW.
Clik here to view.

Johnson & Johnson loses $72m talcum powder suit

(Reuters) — Johnson & Johnson (NYSE:JNJ) was ordered by a Missouri state jury to pay $72 million in damages to the family of a woman whose death from ovarian cancer was linked to her use of the...

View Article
Browsing all 12024 articles
Browse latest View live